Hans Stellingsma – Chairperson
Mr. Stellingsma obtained a Master’s Degree from Utrecht University and a postgraduate degree (M.Phil.) from Glasgow University. He attended the Advanced Management Program at Harvard Business School. He has held numerous senior positions at a range of businesses in the Netherlands. In particular, he has served as a Managing Director at Microsoft’s Dutch subsidiary and as Senior Vice President at KPN N.V. between 1993 and 1996. From 1996 to 1998, he was a member of the managing board of Origin N.V. and then he became the Chief Executive Officer of Content N.V. He was also the Managing Partner at Arthur D. Little in the Netherlands and a Senior Partner with Monitor, both global strategy consulting firms (1999 – 2004). Currently, Mr. Stellingsma is self-employed and serves on the supervisory boards of MTel B.V., Simac Techniek N.V., De Sleutels van Zijl en Vliet and Twinning Holding B.V.

René Kuijten – Vice-chairman
Mr. Kuijten obtained his Medical Doctor Degree from Utrecht University, having obtained additional training at Harvard Medical School and the Mayo Clinics. He completed his Ph.D. at the University of Pennsylvania, where he published, among others, in the New England Journal of Medicine and Cancer Research. He received research awards from the World Health Organization and the International Union Against Cancer, and was honored with the Talma Eijkman Prize and the U-Gene Research Award for his scientific endeavors. He received an MBA from INSEAD in Fontainebleau, France. From 1992 to 2000, Mr. Kuijten was a Senior Consultant at McKinsey & Company, where he was co-leader of the European Pharmaceuticals and Healthcare Practice. He joined Life Sciences Partners in 2001 as a General Partner. Mr. Kuijten is a board member of the NVP (Nederlandse Vereniging van Participatiemaatschappijen) and the Stichting Steun Emma Kinderziekenhuis.

Frans Eelkman Rooda - Member
Mr. Eelkman Rooda obtained a Master’s Degree in Econometrics from Erasmus University Rotterdam and a Master’s Degree in Business Administration from Dartmouth College. In 1977, he started his career with Esso Nederland B.V. and was subsequently employed by Esso Europe Inc. After that, he held positions of increasing responsibility at McKinsey and Company from 1982 to 1987 and 1989 to 1997. From 1987 to 1989, he worked as Department Manager Securities and Syndicates for the Algemene Bank Nederland (ABN) N.V. Mr. Eelkman Rooda was Chief Financial Officer of OPG Group N.V. until early 2008. Currently, he is Chief Financial Officer at Wessanen N.V. He is also a member of the supervisory board of De Lage Landen International B.V.

James Gale - Member
Mr. Gale obtained a Master’s Degree in Business Administration from Chicago Booth School of Business. In 1977 he started his career with E.F. Hutton & Co and Home Insurance Co. Prior to co-founding Signet in 1998, he was head of principal investment activities and head of investment banking for Gruntal & Co. He is currently the Chairman of the Board of Alpex Pharma S.A., and also serves on the Board of Directors of Cedarburg Pharmaceuticals Inc., Cydex Inc., Indevus Pharmaceuticals, Inc., Spepharm BV and Paladin Laboratories. During the past five years, Mr. Gale held board positions at Avantium Holding B.V., Relm Wireless Corp., Indevus Pharmaceuticals, Inc, Molecular Medicine Biosciences and Abrika Pharmaceuticals, Inc.

Nancy de Ruiter - Member
Mrs. De Ruiter has a scientific background and holds a Ph.D. in Medical Biology from the Universities of Utrecht and San Diego. She has held several Supervisory Board positions, including at Kreatech and at De Ruiter Seeds.